By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Nucleic acid production25.35M60.90%
Biologics safety testing16.28M39.10%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
North America127.09M49.03%
Asia Pacific89.38M34.48%
Europe, the Middle East and Africa42.06M16.23%
Latin and Central America662K0.26%